Clinical Trials Logo

Filter by:
NCT ID: NCT04982237 Recruiting - Cervical Cancer Clinical Trials

A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Start date: August 27, 2021
Phase: Phase 3
Study type: Interventional

This is A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate AK104 Plus Platinum-containing Chemotherapy With or Without Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

NCT ID: NCT04982081 Recruiting - Clinical trials for Cardiovascular Diseases

Treating Congestive HF With hiPSC-CMs Through Endocardial Injection

Start date: September 21, 2021
Phase: Phase 1
Study type: Interventional

Heart failure is the primary cause of morbidity and mortality worldwide. Currently drug treatments for heart failure manage the symptoms, but not restore the loss cardiomyocytes due to the very limited regenerative capability in the adult heart. Novel reparative therapies that replace the cardiomyocytes loss are highly demanded to restore the cardiac function. The main purposes of this explanatory study is to investigate the safety and efficacy of the catheter-based endocardial delivery of human iPSC-derived cardiomyocytes in patients with congestive heart failure.

NCT ID: NCT04981691 Recruiting - Clinical trials for Refractory Malignant Solid Neoplasm

Anti-mesothelin CAR-T Cells With Advanced Refractory Solid Tumors

Amaretto
Start date: October 1, 2021
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to study the safety, efficacy, and pharmacokinetics of mRNA-engineered anti-Mesothelin (MESO) Chimeric Antigen Receptor T-Cell (CAR-T cells) therapy in patients with mesothelin expression-positive, advanced solid tumors that have failed at least first-line or second-line therapy.

NCT ID: NCT04981665 Recruiting - Clinical trials for Hepatocellular Carcinoma

A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

Start date: November 8, 2021
Phase: Phase 2
Study type: Interventional

This is an open label, multi-center, phaseâ…¡study to evaluate the efficacy and safety of TACE sequential tislelizumab as adjuvant therapy in hepatocellular carcinoma (HCC) patients who are at high risk of recurrence after curative resection.

NCT ID: NCT04981613 Recruiting - Clinical trials for Diabetic Nephropathy

Study on the Efficacy and Safety of a Novel Tripterygium Wilfordii Preparation in Reducing Proteinuria in Patients With Diabetic Nephropathy

Start date: July 28, 2021
Phase: N/A
Study type: Interventional

The investigators designed a randomized parallel controlled clinical study, selected 98 cases of diabetic nephropathy patients with urinary protein > 1g, randomly assigned into the Kunxian capsule + irbesartan group or irbesartan group, 48 weeks of treatment and follow-up, reduced levels of urinary protein and effective relief time, remission rate as the main end point, estimated glomerular filtration rate (eGFR) drop rate slope for secondary end points, safety events were also collected. To evaluate the efficacy and safety of Kunxian capsule combined with irbesartan in treatment of diabetic nephropathy compared with irbesartan alone.

NCT ID: NCT04981548 Recruiting - Ultrasonography Clinical Trials

Ultrasonography of Optic Nerve Sheath Diameter for Noninvasive Detection of Raised Intracranial Pressure: ORIENT Study

Start date: November 6, 2021
Phase:
Study type: Observational

This study aims to adopt a multi-center large sample size study to define (1) the normal range of Chinese ONSD; (2) ONSD diagnosis for patients with high intracranial pressure; (3) to analyze the correlation between ONSD and intracranial pressure.

NCT ID: NCT04981145 Recruiting - Clinical trials for Primary Sjögren's Syndrome

The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome

Start date: January 14, 2022
Phase: Phase 4
Study type: Interventional

A multi-center, prospective, open-label, randomized controlled study of efficacy and safety of Iguratimod in patients with Primary Sjögren's syndrome

NCT ID: NCT04981093 Recruiting - Inflammation Clinical Trials

Effect of Dexamethasone on Postoperative Inflammatory Factors

Start date: August 15, 2021
Phase: N/A
Study type: Interventional

This topic foe randomized prospective study.Detection of elderly patients with lunmbar spinal postoperative inflammatory substances in the blood and drainage of liquid level ,clear whether low-dose dexamethasone can inhibit the inflammation, the observation of elderly patients with lumbar spinal postoperative drainage star, to explor whether low-dose dexamthasone can reduce postoperative incision drainage, thus impove the postoprative drainage tube pull rate within three days, which in turn reduce because of the place a retrograde infection caused by drainage tube.

NCT ID: NCT04980885 Recruiting - Clinical trials for Acute Myeloid Leukemia

A Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid Leukemia

Start date: August 13, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This is a open label, phase Ib/II study. All patients are diagnosed with AML, Eastern Cooperative Oncology Group (ECOG) performance status 0-3. The purpose of this study is to evaluate the safety and efficacy of AK117 + azacitidine in subjects with AML.

NCT ID: NCT04980742 Recruiting - Prognosis Clinical Trials

Perioperative Risk Factors of Outcomes for Cardiac Surgery: A Retrospective Study

Start date: July 1, 2017
Phase:
Study type: Observational

Based on a review of about 10,000 patients undergoing cardiac surgery under CPB in West China Hospital of Sichuan University and the Second Affiliated Hospital of Zhejiang University, we try to evalute the effect of blood transfusion on outcomes in cardiac surgery.